In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The current prior authorization process in U.S. healthcare constitutes a crisis, according to Jesse Ehrenfeld, immediate past ...

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

When the FDA approves a drug, passing that regulatory bar of safety and efficacy puts it on the path toward likely reimbursement by government and commercial payers. The same has not been true for ...

The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

President Trump’s latest strategy to tackle high drug prices aims to tie the price of U.S. prescription medicines to the prices paid for the same products in other countries, a so-called “most ...

As Congress deliberates what the future of Medicaid funding will look like, healthcare executives are worried. House Republicans proposed Medicaid cuts last month that would have sweeping and ...

One quirk of the most common type of pediatric brain cancer is that as a child gets older, the tumors eventually stop growing. The reasons for this tumor senescence aren’t fully understood, but ...

The country’s treatment modalities for chronic conditions are “completely backwards,” according to HealthSnap CEO Samson Magid. Four million Americans age into the Medicare program every ...